Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population-Reference-Cited by-同舟云学术

Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population

Published:2009-02 Issue:2-3 Volume:107 Page:115-121
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Perez-Iglesias Rocio,Mata Ignacio,Pelayo-Teran Jose M.,Amado Jose A.,Garcia-Unzueta Maria T.,Berja Ana,Martinez-Garcia Obdulia,Vazquez-Barquero Jose L.,Crespo-Facorro Benedicto

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference33 articles.

1. Scale for the Assessment of Negative symptoms (SANS);Andreasen,1983

2. Scale for the Assessment of Positive Symptoms (SAPS);Andreasen,1984

3. A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse;Beasley;J. Clin. Psychopharmacol.,2003

4. Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials;Bushe;J. Clin. Psychiatry,2007

5. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients;Citrome;Psychiat. Serv.,2004

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders;Cochrane Database of Systematic Reviews;2024-07-03

2. Factors influencing concentrations of risperidone and 9‐hydroxyrisperidone in psychiatric outpatients taking immediate‐release formulations of risperidone;Human Psychopharmacology: Clinical and Experimental;2023-11-20

3. Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review;Psychiatry Research;2023-10

4. Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis;International Journal of Neuropsychopharmacology;2023-06-16

5. Antipsychotic-Induced Alterations in Lipid Turnover;Endocrinology;2023-01-30